| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.3 | 4e-16 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.28 | 5e-13 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |